JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation.
Plumé
Gema
G
Thrombosis and Hemostasis Unit, Department of Clinical Pathology, La Fe University Hospital, Valencia, Spain.
Vayá
Amparo
A
Ferrando
Fernando
F
Mira
Yolanda
Y
Orbis
Francisco
F
D000328:Adult; D006502:Budd-Chiari Syndrome / Q000235:genetics* / Q000601:surgery; D005165:Factor V / Q000235:genetics*; D017809:Fatal Outcome; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000150:complications / Q000175:diagnosis* / Q000235:genetics / Q000601:surgery; D010375:Pedigree; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D012307:Risk Factors
C095381:factor V Leiden; D005165:Factor V; C507924:JAK2 protein, human; D053614:Janus Kinase 2